A clinical study on patients with rheumatoid arthritis showed a significant reduction in ADMA after 3 months of treatment with TNF-α inhibitors by increasing endothelial progenitor cells (Spinelli et al., 2013). This evidence concerns the gene TNF and rheumatoid arthritis.